We further investigated whether GLS2 inhibits the Rac1 activity in different human HCC cell lines, including Huh-1 and HepG2 (p53 wild type; WT), Hep3B (p53-null) and Huh-7 cells (p53 mutant). Here, RAC1 is linked to hepatocellular carcinoma.